









Markets
/
Stocks
/
nasdaq-nsrx
/

Nasus Pharma Ltd

NSRX

7.260USD

+0.890+13.97%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

65.77MMarket Cap

LossP/E TTM



Nasus Pharma Ltd

7.260

+0.890+13.97%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Nasus Pharma Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q4

Total equity

Cash, cash equivalents and short-term investments

--284.00

- Cash and cash equivalents

--284.00

Prepaid expenses

--146.00

Other current assets

--27.00

Total current assets

--457.00

Non-current assets

Other non-current assets

--260.00

Total non-current assets

--260.00

Total assets

--717.00

Liabilities

Current liabilities

-Other payables

--1.80K

Accrued expenses

--987.00

Short-term debt and lease liabilities

--0.00

-Short-term debt

--0.00

Other current liabilities

--1.80K

Total current liabilities

--3.93K

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Total liabilities

--3.93K

Shareholders' equity

Common equity

--9.45K

Retained earnings

---12.66K

Capital reserves

--9.43K

Total equity

---3.21K

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

